Amphotericin B-associated hypertension

Annals of Pharmacotherapy

Volumn 30, Issue 7-8, 1996, Pages 765-767

  Le, Ysa ^a,b   Rana, Khurram Z ^c   Dudley, Michael N ^d  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Home Pharmacy of California   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; BACTEREMIA; CANDIDA ALBICANS; CASE REPORT; FEMALE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PNEUMONIA; PRIORITY JOURNAL;

EID: 0030016094     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000711     Document Type: Article

References (11)

1. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
2. Khoo SH, Bond J, Denning DW. Administering amphotericin B - a practical approach. J Antimicrob Chemother 1994;33:203-13.
3. Kintzel PE, Smith GE. Practical guidelines for preparing and administering amphotericin B. Am J Hosp Pharm 1992;49:1156-64.
4. Dukes CS, Perfect JR. Amphotericin B-induced malignant hypertensive episodes (letter). J Infect Dis 1990;161:588.
5. Omizo MKN, Bryant RE, Loveless MO. Amphotericin B-induced malignant hypertension (letter). Clin Infect Dis 1993;17:817-8.
6. Drutz DJ. Rapid infusion of amphotericin B: is it safe, effective, and wise (editorial)? Am J Med 1992;93:119-21.
7. Katz BZ, Cohn RA. Amphotericin B and hypertension (letter). Pediatr Infect Dis J 1994;13:839-40.
8. Bowler WA, Weiss PJ, Hill HE, Huffmeister KA, Fleck RP, Blacky AR, et al. Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function. Antimicrob Agents Chemother 1992;36:2542-3.
9. Craven PC, Gremillion DH. Risk factors of ventricular fibrillation during rapid amphotericin B infusion. Antimicrob Agents Chemother 1985;27: 868-71.
10. Oldfield EC, Garst PD, Hostettler C, White M, Samuelson D. Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations. Antimicrob Agents Chemother 1990;34:1402-6.
11. Sawaya BP, Weihprecht H, Campbell WR, Lorenz JN, Webb RC, Briggs JP, et al. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest 1991;87:2097-107.